It is a pharma public limited company based in Nangloi, Delhi, India, established in 1995.
1995 | Nangloi, Delhi, India | ActiveRamsons Drugs Limited, a active public limited company, was established on 07 April 1995 in Nangloi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74899DL1995PLC067288. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.97 M.
It upholds a compliant status. Its leadership includes Sunil Kumar (Director), Rahul Kumar (Director), Chandra Bhan Singh (Additional Director). Past directors included Virender Kumar Maheshwari, Naveen Sahni, Rahul Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F-125, Adhyapak Nagar,, Nangloi, Delhi, 110041.
U74899DL1995PLC067288
067288
07 April 1995
₹1.00 M
₹0.97 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ramsons Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Kumar | Director | 05 Jan 2010 | Current |
| Rahul Kumar | Director | 28 Mar 2022 | Current |
| Chandra Bhan Singh | Additional Director | 01 Oct 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Feb 2010 | Past |
| Pramod Abcsdd | Additional Director | 01 Feb 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 03 Feb 2010 | Past |
| Pramod Abcsdd | Director | 28 Mar 2022 | Past |
| Pramod Abcsdd | Director | 03 Feb 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ramsons Drugs Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 6642.45% decrease in profit. The company's net worth dipped by a decrease of 4.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Ramsons Drugs had a promoter holding of 33.10% and a public holding of 66.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ramsons Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ramsons Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramsons Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ramsons Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Ramsons Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Rahul Kumar was appointed as a Director was appointed as a Director on 28 Mar 2022 & has been associated with this company since 3 years 9 months . was documented.
Chandra Bhan Singh was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.
The activity Sunil Kumar was appointed as a Director was appointed as a Director on 05 Jan 2010 & has been associated with this company since 16 years 8 days . was completed.
The activity Ramsons Drugs Limited was registered on 07 Apr 1995 with Roc Delhi & aged 30 years 9 months as per MCA records. was completed.
The CIN of Ramsons Drugs Limited is U74899DL1995PLC067288.
Ramsons Drugs Limited is headquartered at F-125, Adhyapak Nagar,, Nangloi, Delhi, 110041.
Ramsons Drugs Limited was incorporated on 07 April 1995.
The current directors of Ramsons Drugs Limited are
The primary industry of Ramsons Drugs Limited is Pharma.
Ramsons Drugs Limited is unlisted.
The authorized capital of Ramsons Drugs Limited is ₹1.00 M, and the paid-up capital is ₹0.97 M.
The compliance status of Ramsons Drugs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX